Novel Linear Peptides with High Affinity to αvβ3 Integrin for Precise Tumor Identification

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Traditional cyclic RGD peptides for targeting alpha-v beta-3 (αvβ3) integrin face limitations in water-solubility and synthesis.
• Development of alternative linear peptides is crucial for improved diagnostic and therapeutic applications.

Purpose of the Study:

• To identify and characterize novel linear peptides with high affinity and specificity for αvβ3 integrin.
• To evaluate the potential of these peptides as alternatives to cyclic RGD ligands.

Main Methods:

• Pharmacophore-based virtual screening and high-throughput molecular docking were employed.
• Competitive binding assays, cellular uptake studies, and molecular dynamics simulations were performed.
• In vivo tumor imaging and targeted therapy models were utilized.

Main Results:

• Two novel linear peptides, RWr and RWrNM, were identified with high affinity and specificity for αvβ3 integrin.
• RWrNM demonstrated superior binding affinity, stability, and specificity compared to cyclic RGD.
• In vivo studies confirmed the peptide-guided tumor imaging and targeted therapy capabilities.

Conclusions:

• The novel linear peptide RWrNM overcomes limitations of cyclic RGD peptides, offering better water-solubility and simplified synthesis.
• RWrNM shows significant potential for diverse diagnostic and therapeutic applications targeting αvβ3 integrin.